• Diagnosis​ ​Info​ ​and​ ​General​ ​Questions

  FDA to Revise ‘Draft Guidance’ on How Treatments for Rare Diseases Are Developed

  Posted by MD forums Moderator on February 6, 2019 at 6:54 pm

  

  Click here to read about the public comment period for the FDA’s revised draft guidance on developing treatments for rare diseases.

  Are you interested in learning more about how the FDA approves treatments for muscular dystrophy and other rare diseases?

  replied 5 years, 2 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply